Business
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Bexotegrast clinical poster selected for featured oral presentation at ATS 2024 Mini Symposium SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) --
About this update from Pliant Therapeutics, Inc.
[{"type":"text","content":"Bexotegrast clinical poster selected for featured oral presentation at ATS 2024 Mini Symposium SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced that the Company will present four scientific posters at the upcoming 2024 American Thoracic Society (ATS) International Conference, taking place in San Diego, California from May 17-22, 2024. The following abstracts are posted on ATS 2024’s online itinerary planner. Title: Post-hoc Analysis of Biomarkers of Interstitial Lung Disease Progression in Participants with Idiopathic Pulmonary Fibrosis Receiving Bexotegrast Over 12-weeks in INTEGRIS-IPFPresenter: Martin L. Decaris, Ph.D., Senior Director, Translational Sciences, Pliant TherapeuticsPoster: 15055Session A68: Unveiling Novel Avenues in IPF TherapiesDate: Sunday, May 19, 2024Presentation Time: 11:30 a.m. – 1:15 p.m. Pacific TimeLocation: TDP15 Title: Bexotegrast Targets TGF-beta Inhibition to Specific Cell Types in the Fibrotic Human LungPresenter: Mahru C. An, Ph.D., Principal Scientist, Pliant TherapeuticsPoster: 11411Session B29: Biomarkers and New Therapeutics Targets in Lung FibrosisDate: Monday, May 20, 2024Presentation Time: 9:15 a.m. – 11:15 a.m. Pacific TimeLocation: San Diego Convention Center, Room 30C-E (Upper Level) Title: Evaluation of Quantitative Imaging in a Phase 2a Study for the Treatment of Idiopathic Pulmonary Fibrosis with Bexotegrast (INTEGRIS-IPF)Presenter: Jonathan G. Goldin, M.D., Ph.D., Professor of Radiology, Medicine and Biomedical Physics at the David Geffen School of Medicine at the University of California, Los AngelesPoster: 10368Session C23: Machine Learned: AI-Driven Solutions in ILD and Lung TransplantDate: Tuesday, May 21, 2024Presentation Time: 9:15 a.m. – 11:15 a.m. Pacific TimeLocation: San Diego Convention Center, Room 33A-C (Upper Level) Pliant was also selected for a featured oral presentation as part of the ATS 2024 Mini Symposiums program. Title: Update on the Safety and Tolerability of Bexotegrast, A Dual-selective Inhibitor of Integrins αvβ6 and αvβ1, in Development for Idiopathic Pulmonary Fibrosis and Primary Sclerosing CholangitisPresenter: Gregory P. Cosgrove, M.D., F...